[1]
2020. Formulation Designing Factors for Development of Repaglinide Transdermal Therapeutic System. International Journal of Pharmaceutical Sciences and Drug Research. 12, 2 (Mar. 2020), 148–158. DOI:https://doi.org/10.25004/IJPSDR.2020.120209.